scholarly article | Q13442814 |
meta-analysis | Q815382 |
P50 | author | Xia Li | Q87811025 |
P2093 | author name string | Jing Zhou | |
P2860 | cites work | The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer | Q39151037 |
Preclinical evaluation of statins as a treatment for ovarian cancer. | Q39195848 | ||
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. | Q39215301 | ||
Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells | Q39656423 | ||
Extrapolation from animals to man: predictions, pitfalls and perspectives | Q39766409 | ||
Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer | Q39911582 | ||
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression | Q39944196 | ||
Differences in antitumor effects of various statins on human pancreatic cancer. | Q40047633 | ||
Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. | Q40727797 | ||
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP | Q41072138 | ||
Cancer of the ovary, fallopian tube, and peritoneum | Q41266914 | ||
Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. | Q41654816 | ||
Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis | Q42467738 | ||
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes | Q42660454 | ||
Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells | Q44507023 | ||
The effect of statins on risk and survival of gynecological malignancies | Q45781693 | ||
Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study. | Q47119934 | ||
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. | Q47139831 | ||
Association between antidepressant medication use and epithelial ovarian cancer risk: a systematic review and meta-analysis of observational studies. | Q48325136 | ||
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
Ovarian cancer | Q54105461 | ||
Why animal studies are often poor predictors of human reactions to exposure. | Q55094903 | ||
Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2) | Q72643659 | ||
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q86063198 | ||
The effect of bisphosphonates on the risk of endometrial and ovarian malignancies | Q87331583 | ||
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase | Q24645348 | ||
Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
Impact of statins on risk and survival of ovarian cancer | Q26801352 | ||
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis | Q30240765 | ||
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis | Q30245592 | ||
The Repurposing Drugs in Oncology (ReDO) Project. | Q33893949 | ||
Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis | Q34041112 | ||
Statin use and reduced cancer-related mortality | Q34645107 | ||
Isoprenoids as mediators of the biological effects of statins | Q34774535 | ||
Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study | Q35135911 | ||
Associations between patients' risk attitude and their adherence to statin treatment - a population based questionnaire and register study. | Q35950060 | ||
Statins and cancer prevention | Q36337970 | ||
Regulation of intracellular actin polymerization by prenylated cellular proteins | Q36531238 | ||
Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials. | Q36806626 | ||
Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. | Q36901717 | ||
Immortal time bias in pharmaco-epidemiology | Q37023172 | ||
Statins in tumor suppression | Q37052337 | ||
Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis | Q37453454 | ||
Impact of statin therapy on survival in epithelial ovarian cancer | Q37779059 | ||
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis | Q38051955 | ||
Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. | Q38428290 | ||
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer | Q38735577 | ||
Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies | Q38781285 | ||
Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials | Q38832643 | ||
Statin use and mortality among ovarian cancer patients: A population-based cohort study. | Q38836074 | ||
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells | Q38968601 | ||
Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies | Q38988107 | ||
Cancer Statistics, 2017. | Q39038674 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 1109-1120 | |
P577 | publication date | 2018-04-02 | |
P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
P1476 | title | Impact of postdiagnostic statin use on ovarian cancer mortality: A systematic review and meta-analysis of observational studies | |
P478 | volume | 84 |
Q92127863 | Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis |
Q93385230 | Current state and outlook for drug repositioning anticipated in the field of ovarian cancer |
Q92923990 | Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis |
Search more.